Research Article
Clostridium difficile in Inflammatory Bowel Disease: A Retrospective Study
Table 2
IBD characteristics.
| | IBD patients with prior CDI () | IBD patients without prior CDI () | Univariate analysis | | value |
| | ≥1 IBD-related hospitalization, n (%) | 32 (72) | 255 (41.7) | | | Number of IBD-related hospitalizations, mean ± SD | 2.9 ± 3.1 | 1.12 ± 2.27 | | | Surgery for IBD, n (%) | 19 (43.2) | 205 (33.5) | | | Biologic as peak IBD therapy, n (%) | 25 (56.8) | 231 (37.8) | | | Salicylate as peak IBD therapy, n (%) | 8 (18) | 189 (30.9) | | | Extraintestinal manifestations of IBD, n (%) | 19 (43) | 174 (28.4) | | | Lowest albumin, mean ± SD | 2.98 ± 0.83 | 3.45 ± 0.79 | | | Peak CRP, mean ± SD | 55.9 ± 64.8 | 37.8 ± 58.3 | | | Peak ESR, mean ± SD | 43.5 ± 31.5 | 35 ± 28.2 | |
|
|
CRP = C-reactive protein, ESR = erythrocyte sedimentation rate.
|
